Top Markets
Coin of the day
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Κατάταξη σε μετοχές #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Τιμή μετοχής
$1.85
Τελευταίος συγχρονισμός: 2024-08-19
Κεφαλαιοποίηση
$3.96M
Αλλαγή (1 ημέρα)
2.78%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο MyMD Pharmaceuticals, Inc. (MYMD)

Κατηγορία

Ιστορικό τιμής μετοχής για την MyMD Pharmaceuticals, Inc. (MYMD)
Υψηλότερη τιμή κλεισίματος: $1.83 στις 2024-08-01

Χαμηλότερη τιμή κλεισίματος: $120.01K στις 2014-01-01
Ιστορικό τιμής μετοχής της MyMD Pharmaceuticals, Inc. από 2014 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2024 -76.01%
2023 -82.01%
2022 -78.21%
2021 60.05%
2020 -42.41%
2019 -86.46%
2018 -78.63%
2017 -81.85%
2016 23.71%
2015 -54.94%
2014 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE